Polli E, Cortelezzi A
Institute of Medical Sciences, University of Milano, Italy.
Acta Haematol. 1987;78 Suppl 1:64-9. doi: 10.1159/000205905.
We report the clinical experience gained with interferon treatment of B and T cell neoplasms, as well as of myeloproliferative and myelodysplastic syndromes.
我们报告了使用干扰素治疗B细胞和T细胞肿瘤、骨髓增殖性疾病以及骨髓增生异常综合征所获得的临床经验。
